Herbal formula may help HIV patients whose immune systems Don't fully recover
NCT ID NCT07698574
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study tests whether adding Qiling Yiqi tablets, a Chinese herbal medicine, to standard HIV therapy can improve immune function in people whose CD4 counts remain low despite successful viral suppression. The trial involves 240 adults with HIV who have been on antiretroviral therapy for years but still have weak immune systems. Participants will take the herbal tablets or a placebo for 48 weeks, and researchers will measure changes in CD4 cell counts and other immune markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Qiling Yiqi Tablets (a Chinese herbal formula containing Astragalus, Codonopsis, and other herbs)
- What this could lead to
- If successful, this could offer a new option to help people with HIV rebuild their immune system when standard therapy alone is not enough.
- What could go wrong
- This is a relatively small, early-stage trial. The herbal tablets may not improve immune function, and there could be side effects or interactions with HIV medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED IMMUNODEFICIENCY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing University of Traditional Chinese Medicine
Beijing, Beijing Municipality, 100029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking HIV's genetic fingerprints reveal where the epidemic is heading?
- Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out
- Could a shot replace daily HIV pills? new trial tests injectable combo
- Long-acting HIV shot studied in patients with severe kidney problems
- RNA vaccine aims to control HIV without daily pills
- Herbal granules aim to revive immune system in HIV patients